Independent Director · Akero Therapeutics, Inc. (AKRO)

Yuan Xu director compensation at Akero Therapeutics (FY2024): $487K

Fiscal year 2024 director compensation for Yuan Xu at Akero Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Yuan Xu’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Yuan Xu and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Akero Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as Akero Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$52,500$0$434,632$0$487,132
FY2023$52,500—$521,064—$573,564

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Akero Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0000950170-25-058964, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Akero Therapeutics, Inc. filed document, accession 0000950170-25-058964. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

Get the Akero Therapeutics Board Governance Report

$487,132 Yuan Xu, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

Akero Therapeutics pays directors a $40,000 cash retainer and $26,000 in Options.

The rest of the Akero Therapeutics board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Andrew ChengDirector—
Graham L. WalmsleyIndependent Director$492,132
Jane HendersonIndependent Director$499,632
Judy ChouIndependent Director$484,632
Mark T. IwickiIndependent Director$519,632
Seth L. HarrisonIndependent Director$478,382
Tomas HeymanIndependent Director$494,632

The full Akero Therapeutics compensation record

free company brief

This page is one director within Akero Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Akero Therapeutics proxy · each links to its own free brief

Order AKRO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report